EyePoint Pharmaceuticals, Inc. (PV3B.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
| Previous close | 7.85 |
| Open | 7.48 |
| Bid | 7.68 x N/A |
| Ask | 7.99 x N/A |
| Day's range | 7.48 - 7.84 |
| 52-week range | 5.25 - 28.60 |
| Volume | |
| Avg. volume | 17 |
| Market cap | 408.342M |
| Beta (5Y monthly) | 1.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?
Intra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- GuruFocus.com
Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
On June 3, 2024, David Guyer, a Director at EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), executed a sale of 11,625 shares of the company.
- Simply Wall St.
Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain
The last three months have been tough on EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT ) shareholders, who have seen the...
© 2024 Yahoo. All rights reserved.